Early complications after dual chamber versus single chamber pacemaker implantation.
This study was performed to compare the frequency of early complications after single chamber versus dual chamber permanent pacemaker implantation. Early complication was defined as one occurring in the 6-week period following implantation. We prospectively analyzed consecutive pacemaker implantation from January 1987 to June 1993 at our regional center. All complications were also analyzed for the relationship to operator experience, the venous access route, and the presence of temporary pacing wire at the time of implantation of the permanent pacing system. A total of 2019 new pacemaker units were implanted during this period. 1733 patients (85.8%) received a VVI pacemaker and 286 (14.2%) a DDD unit. Wound infection occurred in 11 (0.6%) VVI patients and 6 (2.1%) DDD patients. Lead displacement occurred in 18 (1%) VVI patients and 15 (5.2%) DDD patients (11 [3.8%] atrial and 4 [1.4%] ventricular). There were 10 (0.6%) pneumothoraces, 9 (0.5%) hematomas requiring drainage, 1 (0.06%) chylocele, and 2 (0.1%) deaths in the VVI group. There were 2 (0.7%) pneumothoraces, 2 (0.7%) hematomas, and no deaths in the DDD group. There was no significant increase in complications for experienced infrequent implanters (< 12 systems per year). In both groups the subclavian approach was associated with a risk of pneumothorax when compared to the cephalic approach. The rate of wound infection was higher in patients who had a temporary pacing wire in place. The use of prophylactic antibiotics does not appear to affect the incidence of wound infection.(ABSTRACT TRUNCATED AT 250 WORDS)
Regional Cardiac Unit, Papworth Hospital, Cambridge, United Kingdom.
A
A
Chauhan
A A
AA
Grace
S A
SA
Newell
D L
DL
Stone
L M
LM
Shapiro
P M
PM
Schofield
M C
MC
Petch
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001132:Arm / Q000098:blood supply; D002916:Chylothorax / Q000209:etiology; D004868:Equipment Failure; D005260:Female; D006406:Hematoma / Q000209:etiology; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D011030:Pneumothorax / Q000209:etiology; D011292:Premedication; D011446:Prospective Studies; D012307:Risk Factors; D013350:Subclavian Vein; D013530:Surgical Wound Infection / Q000209:etiology
D000900:Anti-Bacterial Agents